Tongji Hospital
Clinical trials sponsored by Tongji Hospital, explained in plain language.
-
New cocktail shrinks liver tumors, opens door to surgery
Disease control OngoingThis study tests a combination of chemotherapy directly into the liver plus two drugs (lenvatinib and cadonilimab) to shrink liver tumors that were too large or widespread for surgery or transplant. The goal is to make these tumors removable, potentially curing the cancer. About …
Phase: PHASE2 • Sponsor: Tongji Hospital • Aim: Disease control
Last updated May 17, 2026 01:00 UTC
-
Gallbladder-Saving stone removal: a gentler approach to gallstones?
Disease control ENROLLING_BY_INVITATIONThis study tests a new procedure that removes gallstones using a thin, flexible tube guided by ultrasound, all while keeping the gallbladder in place. The goal is to see if this method is safe and effective, and whether it can avoid the complications of traditional gallbladder re…
Phase: NA • Sponsor: Tongji Hospital • Aim: Disease control
Last updated May 17, 2026 00:52 UTC
-
Hope for rare disease: drug tofacitinib tested in blau syndrome
Disease control ENROLLING_BY_INVITATIONThis study looks at how well the drug tofacitinib works for people with Blau syndrome, a rare genetic condition causing joint, eye, and skin problems. Researchers will review medical records of 24 patients to see who improves and what factors predict a good response. The goal is …
Sponsor: Tongji Hospital • Aim: Disease control
Last updated May 15, 2026 11:55 UTC
-
Experimental immune therapy takes on Virus-Linked blood cancers
Disease control ENROLLING_BY_INVITATIONThis early-stage trial tests a new treatment called KSD-101 in 9 people with blood cancers tied to the Epstein-Barr virus. The main goal is to check safety and find the best dose. Participants must have tried standard treatments without success. The study does not aim to cure, bu…
Phase: PHASE1 • Sponsor: Tongji Hospital • Aim: Disease control
Last updated May 13, 2026 15:58 UTC
-
New hope for rare disease: drug may ease skin hardening in systemic sclerosis
Disease control OngoingThis study tests whether baricitinib, a drug that calms the immune system, can help people with systemic sclerosis—a rare disease that causes skin to harden and can affect organs like the lungs and heart. About 60 adults with early-stage disease will receive either baricitinib or…
Phase: PHASE4 • Sponsor: Tongji Hospital • Aim: Disease control
Last updated May 13, 2026 15:58 UTC
-
Headache hope: common antidepressant tested as prevention
Prevention OngoingThis study tests whether the drug venlafaxine can reduce how often and how severe tension-type headaches are in people who get them frequently. About 432 adults aged 18-65 with 6-14 headache days per month will take the drug for 12 weeks. Researchers will track headache days and …
Phase: NA • Sponsor: Tongji Hospital • Aim: Prevention
Last updated May 17, 2026 00:53 UTC
-
Migraine sufferers may get new prevention option
Symptom relief OngoingThis study tests whether desvenlafaxine, a medication, can reduce how often and how severe migraines are in people who get them frequently. About 440 adults with episodic migraines will take the drug and report their migraine days over 12 weeks. The goal is to see if this drug ca…
Phase: NA • Sponsor: Tongji Hospital • Aim: Symptom relief
Last updated May 07, 2026 18:39 UTC
-
New study tracks Real-World treatment of Crohn's in kids
Knowledge-focused OngoingThis study follows 100 children with Crohn's disease to see how the condition affects them and which treatments are used in everyday medical practice. Researchers will track symptoms, treatment choices, and how well children improve over 14 and 54 weeks. The goal is to better und…
Sponsor: Tongji Hospital • Aim: Knowledge-focused
Last updated May 17, 2026 00:53 UTC
-
AI tool aims to catch liver cancer spread earlier
Knowledge-focused OngoingThis study looks at whether a machine learning tool can accurately predict the risk of liver cancer spreading to the lungs or bones in over 1,500 adults. Participants continue their usual care, and doctors decide on any extra scans or tests. The goal is to see if this risk-based …
Sponsor: Tongji Hospital • Aim: Knowledge-focused
Last updated May 11, 2026 20:53 UTC